Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Intangibles (2019 - 2023)

Historic Intangibles for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to $12.4 million.

  • ADC Therapeutics' Intangibles fell 1534.46% to $12.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $12.4 million, marking a year-over-year decrease of 1534.46%. This contributed to the annual value of $14.4 million for FY2022, which is 10562816.96% up from last year.
  • As of Q3 2023, ADC Therapeutics' Intangibles stood at $12.4 million, which was down 1534.46% from $13.5 million recorded in Q2 2023.
  • Over the past 5 years, ADC Therapeutics' Intangibles peaked at $14.6 million during Q3 2022, and registered a low of $8825.0 during Q2 2020.
  • Over the past 5 years, ADC Therapeutics' median Intangibles value was $12.8 million (recorded in 2021), while the average stood at $10.9 million.
  • As far as peak fluctuations go, ADC Therapeutics' Intangibles skyrocketed by 13599065.16% in 2021, and later plummeted by 1534.46% in 2023.
  • ADC Therapeutics' Intangibles (Quarter) stood at $9.4 million in 2019, then crashed by 99.9% to $9814.0 in 2020, then skyrocketed by 112840.43% to $11.1 million in 2021, then rose by 29.56% to $14.4 million in 2022, then dropped by 13.94% to $12.4 million in 2023.
  • Its Intangibles stands at $12.4 million for Q3 2023, versus $13.5 million for Q2 2023 and $13.6 million for Q1 2023.